Jane Street’s VIROPHARMA INC VPHM Stock Holding History

Jane Street’s Portfolio VPHM Stock Details VPHM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-18,041	Closed	-$517K	–	3528
2013 Q2	$517K	Buy	+18,041	New	+$476K	0.01%	1420

Other funds holding VPHM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street's VPHM Position: Q3 2013 in Review

Jane Street sold out of VIROPHARMA INC (VPHM) in Q3 2013, closing a stake of 18,041 shares — an estimated $517K sold.

Jane Street first reported a position in VPHM in Q2 2013 and held it in 1 quarter. The position peaked at $517K in Q2 2013. 191 funds tracked by Wall St. Rank hold VPHM as of Q3 2013.

Jane Street reported no remaining VIROPHARMA INC position as of Q3 2013 after selling out during the quarter.
Jane Street sold 18,041 VIROPHARMA INC shares in Q3 2013, an estimated $517K.
Jane Street first reported a position in VIROPHARMA INC in Q2 2013 and held it in 1 quarter.
Jane Street's VIROPHARMA INC position peaked at $517K in Q2 2013.
191 funds tracked by Wall St. Rank held VIROPHARMA INC as of Q3 2013.

Based on Jane Street's 13F filing for Q3 2013, filed 15 Nov 2013.